A chemotherapy bungle that led to the under-dosing of patients with acute myeloid leukaemia was the result of a “disturbing and indefensible failure” in clinical governance, a damning report into the incident says. Ten leukaemia patients treated at the Royal Adelaide Hospital were given incorrect doses of cytarabine over a six-month period between 2014 and ...
Serious clinical governance failures led to Adelaide chemo under-dosing
By Nicola Garrett
22 Sep 2016